ArticleScientific reports2025
Pathogenic genes associated with immune-related genes in graves' disease: a multi-omics Mendelian randomization analysis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Immune-related genes (IRGs) have been implicated in autoimmune diseases, but their causal role in GD remains unclear. We conducted a multi-omics Mendelian randomization (MR) analysis integrating genome-wide association study (GWAS) data from GD patients with blood-based methylation quantitative trait loci(mQTLs), expression QTLs(eQTLs), and protein QTLs(pQTLs). SMR analysis was performed to assess the causal associations between IRGs and GD, followed by HEIDI tests to screen for pleiotropy. Colocalization analysis identified shared genetic determinants. We further validated the findings in Finngen R10 and GWAS catalog dataset and explored the regulatory associations between mQTLs, eQTLs, and pQTLs. Through SMR analysis (P-SMR-multi < 0.05, P-SMR < 0.05, P-HEIDI > 0.01), we identified 301 mQTLs, 27 eQTLs, and 11 pQTLs associated with the risk of GD in our discovery cohort. The validation cohort and colocalization analysis (PP.H4 > 0.5) confirmed 79 mQTLs, 5 eQTLs, and 1 pQTL (MMP9). Integrating mQTL and eQTL data, we identified 6 genes with potential causal associations (TNFRSF4, HLA-H, BACH2, TSHR, IL32, MMP9). Integrating eQTL and pQTL data, we identified FGFRL1. Crucially, a functional enrichment analysis of our candidate genes revealed significant enrichment in key immune pathways, providing strong biological support for our findings. IRGs, particularly FGFRL1, play a causal role in the pathogenesis of GD, providing insights into the molecular mechanisms of GD and potential therapeutic targets for future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.